SCHEMBL8055472

SCHEMBL8055472

Cc1nc(C2CCNCC2)oc1-c1ccc(I)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
USP7 Q93009 3/20 0.35
OPRM1 P35372 1/20 0.35
GPR4 P46093 1/20 0.35
HTR3A P46098 1/20 0.35
KCNH2 Q12809 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
FAAH O00519 2/20 0.34
CASP6 P55212 1/20 0.34
MPO P05164 1/20 0.33
HTR2C P28335 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187243 0.86 FAAH (0.43) NR1H4HTR3AFAAHHTR2CGABRA1
SCHEMBL3098625 0.76 GABRA1 (0.47) NR1H4HTR3AFAAHHTR2CGABRA1
SCHEMBL15006790 0.72 GABRA1 (0.37) NR1H4TLR9TLR8TLR7MPO
SCHEMBL4419637 0.71 NR1H4 (0.65) NR1H4USP7TLR9TLR8TLR7
SCHEMBL3088777 0.71 FAAH (0.47) HTR3AFAAHHTR2CGABRA1GABRB2
SCHEMBL3099656 0.70 HTR2C (0.48) EP300NR1H4FAAHHTR2CMEN1
SCHEMBL187612 0.70 NR4A2 (0.51) NR1H4KCNH2SIGMAR1HTR2CGABRA1
SCHEMBL3097379 0.69 HTR2A (0.45) FAAHHTR2CMEN1KMT2AGABRA1
SCHEMBL3099648 0.69 HTR2A (0.45) FAAHHTR2CMEN1KMT2AGABRA1
SCHEMBL7964498 0.69 MPO (0.49) NR1H4TLR9TLR7MPOMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009050248-A1 SUBSTITUTED PIPERIDINO-DIHYDROTHIENOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed